Press Release

Researchers uncover novel immune cell populations that respond to immunotherapy treatment as well as key molecular factor required for therapy to succeed There have been many success stories for...

The neurodegenerative disease ALS causes motor neuron death and paralysis. However, long before the cells die, they lose contact with the muscles as their axons atrophy. Researchers at Karolinska...

10x Genomics today announced $35 million in funding as an extension of its Series D financing. The round was led by Meritech Capital with Fidelity and...

Veracyte, Inc. announced today that it has entered into a long-term strategic collaboration with Johnson & Johnson Innovation LLC* and the Lung Cancer Initiative at Johnson & Johnson to advance the development and commercialization of novel diagnostic...

  Qlucore, a world leader in the development of bioinformatics software, announces Qlucore Omics Explorer 3.5 of its data analysis software. Key features of the new version include the addition of Templates and an extensive upgrade of plot configuration and ...

Tools allow scientists to understand the activity of naturally occurring microbiomes in response to real-world conditions and diet Researchers from the University of Chicago have developed a...

10x Genomics today announced the acquisition of Stockholm-based Spatial Transcriptomics, a pioneer in the emerging field of spatial genomics. The new field enables researchers to not only see what is in a cell but how cells are organized in relation to one...

Cellecta, Inc. today announced the launch of five DriverMap™ Predesigned RNA-Seq Panels. Each panel measures expression levels of over 1200 expertly curated essential genes selected from...

Cancer arises when cells lose control. Deciphering the "blueprint" of cancer cells - outlining how cancer cells hijack specific pathways for uncontrolled proliferation - will lead to more efficient ways to fight it. Joint effort of scientists from the Weizmann Institute of Science and clinicians from major hemato-oncology departments in Israel succeeded...

Almac Diagnostic Services has launched claraT – a unique software-driven solution, classifying biologically relevant gene expression signatures into a comprehensive, easy-to-interpret report. The claraT report will benefit BioPharma and Academic...